Northwestern Mutual Wealth Management
SGTX

Northwestern Mutual Wealth Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$4 – 3648
2022
Q4 		$4 Hold
1
– – ﹤0.01% 3307
2022
Q3 		$0 Buy
+1
New +$9 ﹤0.01% 3497

Other funds holding SGTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's SGTX Position: Q1 2023 in Review

Northwestern Mutual Wealth Management sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q1 2023, closing a stake of 1 share — an estimated $4 sold.

Northwestern Mutual Wealth Management first reported a position in SGTX in Q3 2022 and held it in 2 quarters. The position peaked at $4 in Q4 2022. 32 funds tracked by Wall St. Rank hold SGTX as of Q1 2023.

  • Northwestern Mutual Wealth Management reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1 Sigilon Therapeutics, Inc. Common Stock share in Q1 2023, an estimated $4.
  • Northwestern Mutual Wealth Management first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Sigilon Therapeutics, Inc. Common Stock position peaked at $4 in Q4 2022.
  • 32 funds tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.